The pharma services industry maintained robust growth through Q4 2025, driven by accelerating demand for outsourced capabilities spanning drug development, manufacturing, and commercialization. Our latest Pharma Services Market Update examines the key dynamics reshaping the sector and highlights where investors are identifying the most compelling opportunities. Key Highlights: Premium Valuations for Integrated “One-Stop-Shop” Capabilities: Rising drug…
Our latest webinar offered a clear, straightforward overview of what it means for healthcare and life sciences companies to partner with private equity. Led by Michael White, the session walked through what PE buyers look for, how businesses are valued, and what business owners should expect in a sale or partnership process. During the webinar,…
Our December Trials Sites Snapshot provides easily digestible information for owner-operators, including: Founders Advisors’ market commentary Public market metrics/KPIs Recent M&A activity Recommended reading Access the report here and reach out to Courtney Davies or Michael White if you would like to have a more individualized conversation about market dynamics and valuation drivers for your…
Our latest webinar offered a clear, straightforward analysis of what shaped the healthcare M&A landscape in 2025 and what it means for companies planning their 2026 strategy. Led by Thomas Dixon, the session walked through seven major themes that defined the year, sector-by-sector performance trends, and what business owners should expect in the current market…
Our latest webinar offered insight into how the advent of digital marketing, coupled with the ever decreasing cost of data analytics, has enabled even small businesses to design and execute elegant, effective marketing strategies. For the right trials site, digital marketing can be a powerful tool for patient recruitment. During the webinar, Michael White gets insight…
The pharma services sector continues to show strong momentum through 2025 as demand for outsourced solutions accelerates across drug development, manufacturing, and commercialization. In our latest Pharma Services Market Update, we break down key trends shaping the space and where investors are finding the most attractive opportunities. Key Highlights: Sustained growth across CDMO and CRO segments: Pharma…